Nanjing Fengkais Pharmaceutical Research and Development

Nanjing Fengkais Pharmaceutical Research and Development is a China-based contract research organization (CRO) and biotechnology company focused on the research and development of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Founded in 2014, the company provides technical services, technology transfer, and customized synthesis for small molecule drugs. Their expertise spans across various therapeutic areas including cardiovascular health and metabolic disorders, primarily serving the domestic Chinese pharmaceutical market. The company operates out of Nanjing and emphasizes high-quality chemical synthesis and process optimization for generic and innovative drug candidates.